The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-(3-(3-fluorobenzamido)phenyl)-4-((4-(4-methylpiperazin-1-yl)phenyl)amino)thiazole-5-carboxylic acid ID: ALA4575423
PubChem CID: 155563694
Max Phase: Preclinical
Molecular Formula: C28H26FN5O3S
Molecular Weight: 531.61
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: CN1CCN(c2ccc(Nc3nc(-c4cccc(NC(=O)c5cccc(F)c5)c4)sc3C(=O)O)cc2)CC1
Standard InChI: InChI=1S/C28H26FN5O3S/c1-33-12-14-34(15-13-33)23-10-8-21(9-11-23)30-25-24(28(36)37)38-27(32-25)19-5-3-7-22(17-19)31-26(35)18-4-2-6-20(29)16-18/h2-11,16-17,30H,12-15H2,1H3,(H,31,35)(H,36,37)
Standard InChI Key: QVCCBJLRSCGOAF-UHFFFAOYSA-N
Molfile:
RDKit 2D
38 42 0 0 0 0 0 0 0 0999 V2000
34.4056 -10.8463 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
35.2306 -10.8463 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.4874 -10.0622 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.8181 -9.5754 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
34.1530 -10.0622 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.7147 -11.5144 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
36.5354 -11.4290 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.0154 -12.0970 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.8353 -12.0122 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.1725 -11.2582 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.6836 -10.5883 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.8655 -10.6765 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.9892 -11.1738 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
39.4732 -11.8432 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.2903 -11.7592 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.6298 -11.0068 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
40.1458 -10.3375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.3223 -10.4205 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.4506 -10.9235 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.3704 -9.8102 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.1997 -9.0019 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.4157 -8.7472 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.8019 -9.2998 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.9773 -10.1103 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.7610 -10.3612 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.2442 -7.9402 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
31.4596 -7.6852 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.2880 -6.8782 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
30.8464 -8.2372 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.0648 -7.9810 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.4520 -8.5322 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.6232 -9.3402 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.4127 -9.5940 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.0222 -9.0410 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.2758 -9.8063 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.8882 -10.3593 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
36.4485 -8.9995 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
28.6674 -8.2769 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 1 0
5 1 2 0
2 6 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 7 1 0
13 14 1 0
13 18 1 0
14 15 1 0
15 16 1 0
16 17 1 0
17 18 1 0
10 13 1 0
16 19 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 20 1 0
5 20 1 0
22 26 1 0
26 27 1 0
27 28 2 0
27 29 1 0
29 30 2 0
30 31 1 0
31 32 2 0
32 33 1 0
33 34 2 0
34 29 1 0
35 36 2 0
35 37 1 0
3 35 1 0
31 38 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 531.61Molecular Weight (Monoisotopic): 531.1740AlogP: 5.40#Rotatable Bonds: 7Polar Surface Area: 97.80Molecular Species: ACIDHBA: 7HBD: 3#RO5 Violations: 2HBA (Lipinski): 8HBD (Lipinski): 3#RO5 Violations (Lipinski): 2CX Acidic pKa: 3.19CX Basic pKa: 7.97CX LogP: 4.24CX LogD: 4.16Aromatic Rings: 4Heavy Atoms: 38QED Weighted: 0.29Np Likeness Score: -1.89
References 1. Guo X, Yang D, Fan Z, Zhang N, Zhao B, Huang C, Wang F, Ma R, Meng M, Deng Y.. (2019) Discovery and structure-activity relationship of novel diphenylthiazole derivatives as BTK inhibitor with potent activity against B cell lymphoma cell lines., 178 [PMID:31234030 ] [10.1016/j.ejmech.2019.06.035 ]